STK17A (DRAK1) at the crossroads of apoptosis, immunity, and cancer: Emerging roles and therapeutic opportunities.

Theranostics · 2026 · PMC13141761 · PMID 42094611

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

High STK17A expression correlates with longer overall survival (OS) in melanoma and showed a favorable trend in cervical and colorectal cancers.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.